Testing and Test Control Notation version 3: TTCN-3 language extensions: Object-oriented features

Testing and Test Control Notation version 3: TTCN-3 language extensions: Advanced matching

Testing and Test Control Notation version 3: TTCN-3 language extensions: Configuration and deployment support

Testing and Test Control Notation version 3: Using JSON with TTCN-3

Testing and Test Control Notation version 3: Using XML schema with TTCN-3

Testing and Test Control Notation version 3: The IDL to TTCN-3 mapping

Testing and Test Control Notation version 3: Using ASN.1 with TTCN-3

Testing and Test Control Notation version 3: TTCN-3 core language

Testing and Test Control Notation version 3: TTCN-3 language extensions: Object-oriented features

Testing and Test Control Notation version 3: TTCN-3 language extensions: Behaviour types

Testing and Test Control Notation version 3: TTCN-3 language extensions: Advanced parameterization

Testing and Test Control Notation version 3: TTCN-3 language extensions: Configuration and deployment support

Testing and Test Control Notation version 3: Using ASN.1 with TTCN-3

Testing and Test Control Notation version 3: TTCN-3 control interface (TCI)

Testing and Test Control Notation version 3: TTCN-3 extension package: Extended TRI

Testing and Test Control Notation version 3: TTCN-3 Language Extensions: Object-oriented features

Testing and Test Control Notation version 3: TTCN-3 core language

Testing and Test Control Notation version 3: TTCN-3 language extensions: Advanced matching

Testing and Test Control Notation version 3: TTCN-3 language extensions: Performance and real time testing

Testing and Test Control Notation version 3: TTCN-3 language extensions: Behaviour types

Testing and Test Control Notation version 3: TTCN-3 language extensions: Advanced parameterization

Testing and Test Control Notation version 3: TTCN-3 language extensions: Configuration and deployment support

Testing and Test Control Notation version 3: TTCN-3 language extensions: Support of interfaces with continuous signals

Testing and Test Control Notation version 3: TTCN-3 runtime interface (TRI)

Testing and Test Control Notation version 3: Using JSON with TTCN-3

Testing and Test Control Notation version 3: TTCN-3 control interface (TCI)

Testing and Test Control Notation version 3: TTCN-3 core language

PSTN/ISDN terminal equipment using IP multimedia core network subsystem; Conformance testing - Part 2: Test suite structure and test purposes

PSTN/ISDN terminal equipment using IP Multimedia core network subsystem; Conformance testing; Part 1: PICS

Cloud interoperability testing for web applications - part 1: Interoperability testing between the CSC and CSP

Interoperability testing requirements of a virtual switch

Testing methodologies of Internet related performance measurements including e2e bit rate within the fixed and mobile operators' networks

Signalling procedures of the probes to be used for remote testing of network parameters

The compatibility testing of SDN-based equipment using OpenFlow protocol

Single-ended line testing for digital subscriber lines

When it comes to testing your user experiences, there are plenty of methods you can use that will get you the information you need. From interviews to assistive technology testing, these methods offer a more streamlined and beneficial process capable of revealing the insights you need to revolutionize your UX. But how can you know […]

The post Testing: User, Usability, and Others You Should Be Using appeared first on Usability Geek

DNA-testing company 23andMe (Nasdaq: ME), once an industry leader that attracted millions of customers, including rapper Snoop Dogg and investor Warren Buffett, has announced significant cuts to its operations, with plans to lay off 200 employees or roughly 40% of its workforce. The company also said it will discontinue development of its therapeutic programs. Here’s what to know about the latest development and what led up to it.

Board exodus

The latest move comes as the company looks to stabilize after facing significant challenges, including the resignation of all seven independent board members in October.

Data breach

Last year, 23andMe suffered a massive data breach when hackers accessed the personal information of 6.9 million users. The incident led to a class-action lawsuit, which, in September, 23andMe agreed to settle for $30 million.

The problem with SPACs

In 2021, 23andMe went public through a merger with a special purpose acquisition company, or SPAC. It later expanded into drug-discovery and weight-loss sectors. However, as DNA test kit sales declined, so did its financial health. By fiscal 2023, it reported a $312 million net loss, with its stock down 98% since going public, currently at about $4 after a reverse stock split in October 2024.

Separate reports have found that things have often not ended well for companies that took advantage of the pandemic-era SPAC boom, which led to billions in losses for investors and a number of bankruptcies for companies.

What’s next for 23andMe and its employees?

The layoffs are expected to result in $12 million in severance, termination, and transition-related costs and are part of a broader plan to streamline the business and achieve annual cost savings of $35 million.

The company says it is exploring various strategic options for its therapeutic programs, including potential licensing agreements and the sale of assets in its development pipeline.

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said Anne Wojcicki, cofounder, CEO, and chair of the board, in a statement.

Shares of 23andMe were up almost 6% to $4.87 on the news, which was announced late yesterday. The stock is down more than 73% year to date.

Never lose a gem of a tweet to the ravages of the algorithmic timeline again.

Read more: Twitter is testing a feature allowing users to bookmark tweets

GAF Energy plans to build a state-of-the-art solar roofing testing facility in collaboration with Sandia National Laboratories — with support from the U.S. Department of Energy — to enhance understanding of solar shingles' benefits for heating and air conditioning efficiency.

Tim Odom, director of Business Technology Solutions Development at Vidoori, joins host John Gilroy on this week's Federal Tech Talk, to explain how high-performance testing can help federal leaders complete major tasks on time and under budget.

The post The value of high performance testing first appeared on Federal News Network.

The Army I Corps used the recent Yama Sakura 85 exercise to further prove out how to create a single, secure network to share information with allied partners.

The post How the Army is always testing, training on zero trust first appeared on Federal News Network.

Homegrown, modernized legacy and software as a service applications all benefit from continuous testing for performance and functionality.

The post Continuous code testing ensures enterprise apps keep working first appeared on Federal News Network.

Some parts of the system are more difficult to automate, including operations like biometric fingerprinting.

The post At CBP, automated software testing is integral to the mission first appeared on Federal News Network.

Public health experts generally agree that, in spite of improvements, the U.S. still falls short on the testing needed to combat the COVID-19 pandemic. The official who oversees the country's testing efforts, however, maintains the U.S. is doing well on testing now and will soon be able to expand testing greatly using newer, point-of-care tests that deliver quick results. In an interview with NPR's Morning Edition , Adm. Brett Giroir pointed out the U.S. is currently conducting more than 700,000 tests a day. He argued that some parts of the country are already conducting enough tests to contain outbreaks. "We know that in areas of the country right now that have appropriate mitigation, that the testing we have is sufficient. We know right now that the testing we have is dense enough that we can detect very sensitively where there's going to be a problem," the assistant secretary for health in the Department of Health and Human Services told NPR. A recent analysis for NPR by Harvard

Copyright 2020 NPR. To see more, visit https://www.npr.org.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

I seem to remember someone here recommending a tabletop at-home device for Covid testing (maybe NAAT?) that's approved in the European market but not in the US. Can someone here remind me?

Context: We've got an ambiguous rapid antigen test result for COVID in our house. The line is so faint that it is not pink or red, although two out of three of us see something there, like a shadow. We'd hoped to confirm with PCR so we can plan (eg what are the chances we'll need to cancel our Thanksgiving trip to see my elderly mother in her nursing home?) but we learned that molecular testing isn't offered in our region anymore.

I know that I might not be able to buy anything that is immediately useful for this situation, but since Covid isn't going anywhere, maybe this is worth an investment. We do plan to follow up with more RATs over the next few days.

We do know that CDC guidelines don't require us to care. I'm not worried for my kid at all, she's only mildly ill. I just want to do the right things to limit spread, here and in future.

Saving sharks with electricity and cougars and grizzlies return to Manitoba

The new guidance comes after blood tests for 115 farmworkers in Michigan and Colorado showed that eight workers -- or 7% — had antibodies that indicated previous infection with the virus known as Type A H5N1 influenza.